Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

902
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
902
Energy to Drive Translocation01:37

Energy to Drive Translocation

2.8K
Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
2.8K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.4K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

5.4K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
5.4K
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

5.1K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.1K
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

5.6K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Local control of dopamine release in nucleus accumbens gates opioid withdrawal aversion.

bioRxiv : the preprint server for biology·2026
Same author

Dopamine and serotonin inversely modulate D2 medium spiny neurons to regulate cocaine reward.

Nature communications·2026
Same author

Serotonin modulates nucleus accumbens circuits to suppress aggression in mice.

Nature communications·2026
Same author

No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of pain.

Nature communications·2026
Same author

Serotonin modulates nucleus accumbens circuits to suppress aggression.

bioRxiv : the preprint server for biology·2025
Same author

A chemogenetic ligand-receptor pair for voltage-gated sodium channel subtype-selective inhibition.

bioRxiv : the preprint server for biology·2025

Video Experimental Relacionado

Updated: Jan 30, 2026

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs
09:37

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs

Published on: August 31, 2009

25.3K

La modulación colinérgica de la liberación de dopamina impulsa el comportamiento de esfuerzo.

Gavin C Touponse1, Matthew B Pomrenze2, Teema Yassine1

  • 1Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.

Nature
|January 28, 2026
PubMed
Resumen

El esfuerzo amplifica las respuestas de dopamina a las recompensas, impulsadas por la acetilcolina que actúa sobre los axones de dopamina en el núcleo accumbens. Este mecanismo explica por qué valoramos las recompensas ganadas con más esfuerzo y motiva el comportamiento de esfuerzo.

Más Videos Relacionados

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

14.3K
Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice
09:35

Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice

Published on: January 20, 2015

9.3K

Videos de Experimentos Relacionados

Last Updated: Jan 30, 2026

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs
09:37

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs

Published on: August 31, 2009

25.3K
Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

14.3K
Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice
09:35

Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice

Published on: January 20, 2015

9.3K

Área de la Ciencia:

  • La neurociencia es la neurociencia.
  • Biología del comportamiento Biología del comportamiento.
  • La neuroquímica es la neuroquímica.

Sus antecedentes:

  • Los individuos a menudo prefieren recompensas que requieren más esfuerzo para obtener, un fenómeno que mejora la aptitud evolutiva.
  • Los fundamentos neuronales de esta valoración de la recompensa basada en el esfuerzo siguen siendo en gran medida poco claros.

Objetivo del estudio:

  • Investigar los mecanismos neuronales por los cuales el esfuerzo influye en el procesamiento de la recompensa y motiva el comportamiento.
  • Aclarar los roles de la dopamina y la acetilcolina en la amplificación de la recompensa dependiente del esfuerzo.

Principales métodos:

  • In vivo electrofisiología y farmacología en modelos de roedores.
  • Medición de la liberación de dopamina en el núcleo accumbens.
  • Manipulación de la señalización colinérgica en los axones de la dopamina.
  • Ensayos conductuales que miden la elección por esfuerzo.

Principales resultados:

  • Las recompensas de alto esfuerzo desencadenan la liberación de acetilcolina en el núcleo accumbens, lo que mejora la liberación de dopamina.
  • La acetilcolina actúa sobre los receptores nicotínicos en las terminales del axón de la dopamina para aumentar la liberación de dopamina.
  • El bloqueo farmacológico de la modulación colinérgica perjudica selectivamente el comportamiento de esfuerzo, sin afectar el consumo de recompensa de bajo esfuerzo.

Conclusiones:

  • El esfuerzo amplifica la señalización de la dopamina a las recompensas a través de la modulación local de acetilcolina de los axones de la dopamina.
  • Este mecanismo proporciona una base neurobiológica para el valor de las acciones con esfuerzo.
  • Los hallazgos concilian las observaciones in vitro e in vivo sobre las interacciones acetilcolina-dopamina en las vías de recompensa.